Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B
NCT00646503 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2017-06-22
Summary
This study will explore efficacy and safety of Telbivudine in the fifth year of treatment.
Conditions
- Hepatitis B, Chronic
Interventions
- DRUG
-
Telbivudine
600 mg/day, oral telbivudine for 52 weeks
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis · Novartis
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-03-31
- Primary Completion
- 2009-09-30
- Completion
- 2009-09-30
Countries
- China
Study Locations
More Related Trials
-
Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B
NCT00131742 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B
NCT00877149 ·Status: COMPLETED ·Phase: PHASE4
-
An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B
NCT00467545 ·Status: COMPLETED ·Phase: PHASE4
-
To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)
NCT00537537 ·Status: COMPLETED ·Phase: PHASE4
-
A Two-year Study of Telbivudine in HBeAg Negative Hepatitis
NCT01521975 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine
NCT00640588 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks
NCT00862706 ·Status: WITHDRAWN ·Phase: PHASE4
-
Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies
NCT00142298 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues on the Hepatitis B Surface Antigen of Virally Suppressed Subjects With Chronic Hepatitis B
NCT05256823 ·Status: UNKNOWN ·Phase: PHASE2
-
Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
NCT00324961 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Telbivudine to Prevent Perinatal Transmission
NCT00939068 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)
NCT01380951 ·Status: UNKNOWN ·Phase: PHASE4
-
The Study on Clinical Outcome and Treatment Optimization of Chronic Hepatitis B Patients With Hypoviremia
NCT05357183 ·Status: UNKNOWN
-
Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B
NCT00412529 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) Infection
NCT01480492 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B
NCT00606099 ·Status: WITHDRAWN ·Phase: PHASE4
-
Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients
NCT00441974 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability of HH-003 Injection in Participants With Chronic Hepatitis B Virus Infection
NCT05542979 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)
NCT00804622 ·Status: COMPLETED ·Phase: PHASE2
-
ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy
NCT00823342 ·Status: TERMINATED ·Phase: PHASE3
-
Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection
NCT03903796 ·Status: COMPLETED ·Phase: PHASE3
-
A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B
NCT00857675 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
NCT01829685 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)
NCT06829329 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B
NCT04180150 ·Status: UNKNOWN ·Phase: PHASE2